Furthermore, we found that parecoxib suppressed ESCC growth in heterotopic tumor models.<h4>Conclusion</h4>Parecoxib inhibits ESCC progression, including cell cycle, proliferation, invasion, and migration, via the PDK1-AKT signaling pathway. The gene discussed is AKT1; the disease is neoplasm.